HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One
Medical, Inc. (OTC Bulletin Board: CSKI; "China Sky" or "the Company"), a
China based manufacturer, marketer and distributor of pharmaceutical,
medicinal and diagnostic products, announced today the changes in
management team. The changes were made in conjunction with the Company
filing an application to list its shares on the American Stock Exchange.
As of May 7, 2008, Mr. Haifeng "Steve" Wang resigned as a secretary and
member of the Board of Directors (the "Board") of China Sky One Medical,
Inc. for personal reasons and Ms. Xiaoyan Han resigned as Chief Financial
Officer and was appointed as Vice Chairman of the Board.
Simultaneously, Mr. Xiaoqing Liao was appointed to the Board and was
appointed as Chief Financial Officer and Secretary of the Company and to
similar positions with the Company's operating subsidiaries.
Xiaoqing Liao has been employed with the company in various capacities
since March 2008. From 2005 to 2008, he worked as an acting Corporate
Secretary for Zhongjin Gold Corporation, a PRC state-owned company listed
on the Shanghai Stock Exchange, where he assisted with various
restructuring efforts. Prior to Zhongjin, Mr. Liao was a law clerk in the
Law Department of China National Gold Group, a large mining company
controlled by the Central State-Owned Asset Committee, where his
responsibilities included reporting directly to senior management on
international economic and trade issues. From 2003 to 2004, he worked as
investment manager for Unisar Avionics LTD, an international trading
company in the United Kingdom. Mr. Liao earned a certification from the
Shanghai Stock Exchange to act as a company secretary for companies listed
on such exchange in the PRC. He graduated from the Zhongnan University of
Economic and Law where he received a Bachelor or Arts degree in law with a
minor in accounting and international finance in 2003. Mr. Liao also
studied for one and half years in University of Newcastle upon Tyne in the
United Kingdom, where he received a Merit LLM degree in international
economics, international finance law and international accounting in 2004.
"China Sky One strives to achieve the high standards in financial
reporting as required by a U.S. listed public company. We look forward to
working with our newly appointed CFO and Board Secretary whom we hope will
be able to continue to represent the interests of all our shareholders
throughout the world and continue to deliver outstanding returns for our
shareholders," said Mr. Yan-qing Liu, Chairman, CEO and Director of China
Sky One Medical, Inc.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a China based
company engaged in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic kit products. Through its wholly-
owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology
Company and Harbin First Bio-Engineering Company Limited the Company
manufactures and distributes over-the-counter pharmaceutical products as
its primary revenue source. For more information, visit
http://www.skyonemedical.com .
Safe Harbor Statement
Certain statements made in the press release constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. These statements can be identified by the use of
forward-looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the
negative thereof or comparable terminology. Additional statements that are
necessarily forward looking in nature also include, without limitation,
statements relating to our research and development activities, expected
revenues or sales margins, results of recent acquisitions and our ability
to increase sales and expand our presence in the global market place, and
risks or uncertainties relating to PRC socioeconomic issues. Such
statements typically involve risks and uncertainties and may include
financial projections or information regarding our future plans, objectives
or performance. The Company cannot provide any assurance that it will be
able to establish listing of its securities on any national or regional
securities exchange or market system. Actual results could differ
materially from the expectations reflected in such forward- looking
statements as a result of a variety of factors, including the inability of
the company to meet listing standards of an exchange, risks associated with
the effect of changing economic conditions in The People's Republic of
China, variations in cash flow, reliance on collaborative retail partners
both in China and throughout the world and on new product development,
variations in new product development, risks associated with rapid
technological change, and the potential of introduced or undetected flaws
and defects in products, and other risk factors detailed in reports filed
with the Securities and Exchange Commission from time to time.
For more information, please contact:
China Sky One Medical, Inc.
Mr. Liao Xiaoqing, CFO
Tel: +86-1591-067-2198
Email: tdrhan@163.com
CCG Elite Investor Relations Inc.
Mr. Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
Website: http://www.ccgelite.com
SOURCE China Sky One Medical, Inc.
 back to top
Related links:
http://www.skyonemedical.com
CONTACT:
Mr. Liao Xiaoqing, CFO of China Sky One
Medical, Inc. at +86-159-1067-2198 or tdrhan@163.com; or Mr.
Crocker Coulson, President of CCG Elite Investor Relations Inc.
at +1-646-213-1915 (New York) or crocker.coulson@ccgir.com
|
